Mantle Cell Lymphoma (MCL) Recruiting Phase 2 Trials for Mycophenolate mofetil (DB00688)

Also known as: Lymphoma, Mantle-Cell / Mantle Cell Lymphoma / Mantle-Cell Lymphoma / Lymphoma, Mantle- Cell / Lymphoma, Mantle Cell / Mantle-Cell Lymphomas / B cell lymphoma / Centrocytic lymphoma / Mantle cell lymphoma NOS / Mantle cell lymphomas

IndicationStatusPhase
DBCOND0071979 (Mantle Cell Lymphoma (MCL))Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02661035Allo HSCT Using RIC for Hematological DiseasesTreatment
NCT02722668UCB Transplant for Hematological Diseases Using a Non Myeloablative PrepTreatment
NCT03246906Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell TransplantationTreatment
NCT00719888Umbilical Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With Hematologic DiseaseTreatment
NCT03128359High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell TransplantSupportive Care
NCT03674411Trial Evaluating MGTA-456 in Patients With High-Risk MalignancyTreatment